Renowned medic and respected Murang’a businessman Dr. Moses Mwangi has welcomed the government’s announcement of a major shift in Kenya’s polio immunization strategy.
The Ministry of Health recently confirmed that the country will transition from the Oral Polio Vaccine (OPV) to the Inactivated Polio Vaccine (IPV), which is administered through injection.
Dr. Moses described the move as a long overdue significant milestone in the nation’s public health journey, noting that the switch aligns Kenya with global best practices in disease prevention and eradication.
“This transition marks a new chapter in our fight against polio. It enhances protection for our children and reflects Kenya’s commitment to modern, evidence-based immunization strategies,” he said.
The adoption of the IPV is expected to strengthen the country’s capacity to eliminate the poliovirus and safeguard future generations from preventable diseases.